On 2 March 2015, Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) reported a loss of 44 cents per share in the fourth quarter of 2014, much wider than both the Zacks Consensus Estimate of a loss of 38 cents and the year-ago quarter figure of 21 cents. On Thursday shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) closed at $13.19. Company’s sales growth for last 5 years was 42.30% and EPS growth for next 5 years is recorded as 30.00%.
On 2 March 2015, Puma Biotechnology, Inc. (NYSE:PBYI) announced financial results for the fourth quarter and year ended December 31, 2014. Unless otherwise stated, all comparisons are for the fourth quarter and full year 2014 compared to the fourth quarter and full year 2013, respectively. Based on accounting principles generally accepted in the United States (GAAP), Puma reported a net loss applicable to common stock of $47.5 million, or $1.57 per share, for the fourth quarter of 2014, compared to a net loss of $15.9 million, or $0.55 per share, for the fourth quarter of 2013. Net loss applicable to common stock for the full year 2014 was $142.0 million, or $4.73 per share, compared to $54.6 million, or $1.90 per share, for the full year 2013. Puma Biotechnology, Inc. (NYSE:PBYI) in last trading activity moved up 17.50% to close at $243.17. Company weekly performance is 18.07% while its quarterly performance stands at 8.08%. Puma Biotechnology, Inc. (NYSE:PBYI) is -12.96% away from its 52 week high.
On 2 March 2015, MBIA Inc. (NYSE:MBI) reported combined operating income of $185 million for the year ended December 31, 2014 compared with a combined operating loss of $15 million in 2013. The Company’s combined operating income for the fourth quarter of 2014 was $22 million compared with a combined operating loss of $383 thousand for the same period of 2013. The increase in combined operating income for the three months ended December 31, 2014 compared with the same period of 2013 was driven primarily by a lower provision for income taxes. On last trading day MBIA Inc. (NYSE:MBI) remains unchanged to close at $9.37. Its volatility for the week is 4.38% while volatility for the month is 3.05%. MBI’s EPS growth for past 5 years was 16.10%. MBIA Inc. (NYSE:MBI) monthly performance is 10.50%.
Ericsson (NASDAQ:ERIC) and Intel have agreed to help network operator customers build their own data centres for the cloud, giving them move competitiveness against cloud-based giants like Google, Facebook or Amazon. The information was unveiled during the Mobile World Congress in Barcelona. On Thursday shares of Ericsson (NASDAQ:ERIC) closed at $12.77. Company’s sales growth for last 5 years was 2.00% and EPS growth for next 5 years is recorded as 8.25%.
Zacks downgraded shares of Peoples Bancorp Inc. (NASDAQ:PEBO) from a neutral rating to an underperform rating. Their analysts now have a $22.50 price target on that stock. On last trading day Peoples Bancorp Inc. (NASDAQ:PEBO) moved up 0.21% to close at $23.61. Its volatility for the week is 1.12% while volatility for the month is 1.93%. PEBO’s sales growth for past 5 years was -4.70% and its EPS growth for past 5 years was 44.00%. Peoples Bancorp Inc. (NASDAQ:PEBO) monthly performance is 0.64%.